TSE:2269 | 11/15/2024 | Notice regarding UN WFP emergency support (374KB) | https://www.meiji.com/pdf/news/2024/241115_02.pdf |
TSE:2269 | 11/15/2024 | LGBTQ+initiatives at work "PRIDE Index 2024" The three Meiji group companies have won the highest rating "Gold" for the second consecutive year!Meiji Co., Ltd. also acquired "Rainbow Certification" for the second consecutive year (793KB) | https://www.meiji.com/pdf/news/2024/241115_01.pdf |
TSE:4151 | 11/15/2024 | Kyowa Kirin acquired gold certification for the 3rd consecutive year (594KB) for the 3rd consecutive year (594KB) | https://www.kyowakirin.co.jp/pressroom/news_releases/2024/pdf/20241115_01.pdf |
TSE:4523 | 11/15/2024 | Started broadcasting a TV commercial for the purpose of enlightenment of MCI (mild cognitive impairment) nationwide -my daughter is always worried that "I said it a while ago." | https://www.eisai.co.jp/news/2024/news202485.html |
TSE:4523 | 11/15/2024 | Received an approval recommendation from the European Pharmaceutical Committee (CHMP), the early Alzheimer's disease treatment agent | https://www.eisai.co.jp/news/2024/news202484.html |
TSE:2269 | 11/14/2024 | Started a demonstration experiment at the Farm Note Group Ranch using the first methane reduction feed "BOVAER®" (554KB) | https://www.meiji.com/pdf/news/2024/241114_01.pdf |
TSE:2269 | 11/14/2024 | Notice about investment from Meiji Seika Falma (454KB) | https://www.meiji-seika-pharma.co.jp/pressrelease/2024/detail/pdf/241114_01.pdf |
TSE:4536 | 11/14/2024 | FANTASISTA UTAMARO Design Sante FX Limited Original Design Package appeared on Thursday, November 14, 2024 at pharmacies and drugstores nationwide. | https://www.santen.com/ja/news/2024/2024_1/20241114 |
ABBV | 11/14/2024 | AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations | https://news.abbvie.com/2024-11-14-AbbVie-Awards-20-Individuals-Living-With-Migraine-To-Support-Career-Aspirations |
BIIB | 11/14/2024 | Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease | https://investors.biogen.com/news-releases/news-release-details/eisai-receives-positive-opinion-chmp-european-union-lecanemab |
GSK | 11/14/2024 | Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma | https://www.gsk.com/en-gb/media/press-releases/blenrep-shows-overall-survival-benefit-in-head-to-head-dreamm-7-phase-iii-trial-for-relapsedrefractory-multiple-myeloma/ |
JNJ | 11/14/2024 | Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study | https://www.jnj.com/media-center/press-releases/nipocalimab-demonstrates-significant-clinical-improvement-in-disease-activity-and-igg-reduction-in-phase-2-sjogrens-disease-study |
JNJ | 11/14/2024 | Johnson & JohnsonMedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue Solutions | https://www.jnj.com/media-center/press-releases/johnson-johnson-medtech-announces-strategic-agreement-with-responsive-arthroscopy-to-expand-sports-soft-tissue-solutions |
MRK | 11/14/2024 | Merck to Participate in the Jefferies London Healthcare Conference | https://www.merck.com/news/merck-to-participate-in-the-jefferies-london-healthcare-conference-2/ |
MRK | 11/14/2024 | Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd. | https://www.merck.com/news/merck-enters-into-exclusive-global-license-for-lm-299-an-investigational-anti-pd-1-vegf-bispecific-antibody-from-lanova-medicines-ltd/ |